HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wellness (Dietary Supplements)

Set Alert for Wellness

Regulation / Legislation Explore this Topic

Set Alert for Regulation and Legislation {Wellness}

Latest From Regulation & Wellness

US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes

It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.

Coronavirus COVID-19 OTC Drugs

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.

United States Legal Issues

Supplement Firms Should Tighten Supply Gatekeeping As FDA Suspends Inspections

Supplement manufacturers should increase vigilance over supply chains after FDA suspends routine facility inspections and certain requirements of its foreign supplier verification program. Firms should verify even their trusted supplier’s next few certificates of analysis and step-up adverse event monitoring.

Coronavirus COVID-19 Dietary Supplements
See All

Latest From Legislation & Wellness

US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes

It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.

Coronavirus COVID-19 OTC Drugs

US FDA Reopens Door For CBD Safety Data, But NPA Says Window Closing For Setting Safe Level

As it recently told Congress it would, FDA reopens docket on “Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived,. "Reopening the comment period will do nothing to protect public health when the FDA is already sitting on a ticking time bomb," says NPA head Daniel Fabricant.

Dietary Supplements FDA

Confidentiality For Proprietary Information Drives FDA Plan To Generate More CBD Safety Data

In report to Congress about determining an enforcement discretion policy for CBD-containing non-drug products, FDA described challenges it faces, largely unique in its history, in determining whether hemp-derived ingredients are safe in food, supplements and other products that already are “sold increasingly widely."

Dietary Supplements FDA
See All

Business Explore this Topic

Set Alert for Business {Wellness}

Latest From Deals & Wellness

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

Dietary Supplements Sales & Earnings

Podcast: How GSK's £1bn OTC Brand Sale Is Reshaping The Global Market

As GSK continues to sell off OTC assets in the wake of its merger with Pfizer, HBW Insight Editors Tom Gallen and David Ridley discuss how this torrent of M&A activity is shaking up the global consumer healthcare market. 

Market Intelligence Business Strategies

Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch

The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.

Italy Deals
See All

Latest From Business Strategies & Wellness

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

Dietary Supplements Sales & Earnings

Light At End of Tunnel As Some Conferences Reschedule, But Lights Off For Others In 2020

CHPA’s Regulatory, Scientific & Quality Conference rescheduled for 1-2 September and the Dietary Supplements Regulatory Summit for 16 September. Several spring conferences canceled due to Covid-19 will not be rescheduled, groups say.

Coronavirus COVID-19 Dietary Supplements

Supplement Firms Should Tighten Supply Gatekeeping As FDA Suspends Inspections

Supplement manufacturers should increase vigilance over supply chains after FDA suspends routine facility inspections and certain requirements of its foreign supplier verification program. Firms should verify even their trusted supplier’s next few certificates of analysis and step-up adverse event monitoring.

Coronavirus COVID-19 Dietary Supplements
See All

Latest From Sales & Earnings & Wellness

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

Dietary Supplements Sales & Earnings

RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

Business Strategies Sales & Earnings

Perrigo's Infant Formula Already A Key Sales Driver, And Nutrition Sector Takes Larger Role Ahead

OTC private label giant said gaining another grocery chain as an infant formula customer was a key sales driver in the 2019 Q4, with nutrition sales up 21% to account for 17% of Americas consumer health sales growth. The firm plans to re-enter the broader VMS space, but infant formula helped its global consumer health net sales reach $1.1bn in the October-December period.

Sales & Earnings OTC Drugs
See All

Latest From Legal Issues & Wellness

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.

United States Legal Issues

Fewer Arrows Left In Quincy's Quiver To Defend Against FTC's Prevagen Supplement Complaint

"There is no need to litigate the same issue again," says District Judge Louis Stanton in granting most of the joint motions by FTC and New York attorney general to strike Quincy Bioscience's proposed defenses. The judge denied other motions, including whether NY state laws are applicable, saying a trial is needed to weigh the evidence.

Dietary Supplements Ad Complaints

Federal Court Stays Class Action Against CBD Firm Green Roads To Await FDA Rulemaking

Plaintiffs against Florida-based Green Roads used certificates of analysis the company makes freely available to consumers to determine that batches of two of the company’s products contained “significantly” less cannabidiol versus labeled amounts. A Florida federal court rejected the firm’s motion to dismiss, but it is interested in seeing how FDA rulemaking develops.

United States Legal Issues
See All

Marketing Explore this Topic

Set Alert for Marketing {Wellness}

Latest From Launches & Wellness

Health And Wellness Trademark Review 24 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks OTC Drugs

C&D Extends Vitafusion Line Again, Catering To Children's Sleep, Other ‘Unmet’ Nutrition Needs

Church & Dwight extends its vitafusion gummy line with supplements for unmet nutrition needs, including skin, immunity, children’s sleep and teen nutrition. The products will launch in broad distribution, following the brand’s recently added Goodness and CBD lines.

Dietary Supplements Commercial

Health And Wellness Trademark Review 3 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks OTC Drugs
See All

Latest From Ad Campaigns & Wellness

Pandemic Could Turn Supplement Firms To Drug Production, Helping Fill Public Health Gaps

The Covid-19 pandemic could push food and supplement manufacturers to switch to manufacturing OTC or Rx drugs to help fill public health gaps, says a former deputy director of FDA's Office of Dietary Supplement Programs. Many marketers are well equipped to make OTC drugs, he added in FDLI webinar.

Coronavirus COVID-19 Dietary Supplements

Perrigo Crowned Company of the Year and Pfizer’s Viagra Is Best Brand At OTC Marketing Awards 2020

Perrigo was the night's biggest winner at the OTC Marketing Awards 2020, with Teva and The Mentholatum Company also among the firms recognized for outstanding consumer healthcare campaigns.

Ad Campaigns Launches

Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch

The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.

Italy Deals
See All

Latest From Ad Complaints & Wellness

Vitafusion Absorption Claim Review May Touch Supplement Industry Nerve About Disclosures

Council of Better Business Bureaus division, reviewing Pharmavite challenge, found Church & Dwight doesn't support or sufficiently qualify “clinically proven absorption” claims for vitafusion vitamin C and D3 products in a decision that swung on a corollary to an oft-cited standard for consumer health product advertising, that results of tests on separate ingredients are not relevant to claims for products.

Dietary Supplements Ad Complaints

Cannabidiol Patch With 14-Hour Delivery OK In UK, But Not Pain, Anxiety And Diabetes Claims

UK advertising regulator says an ad catalog retailer claiming a CBD patch could reduce chronic pain, anxiety and diabetes violated advertising codes. The agency says claims including the product penetrated quickly through skin were medicinal and not approved by the UK or EU.

Dietary Supplements Ad Complaints

Fewer Arrows Left In Quincy's Quiver To Defend Against FTC's Prevagen Supplement Complaint

"There is no need to litigate the same issue again," says District Judge Louis Stanton in granting most of the joint motions by FTC and New York attorney general to strike Quincy Bioscience's proposed defenses. The judge denied other motions, including whether NY state laws are applicable, saying a trial is needed to weigh the evidence.

Dietary Supplements Ad Complaints
See All
UsernamePublicRestriction

Register